Neuroprotective effects of testosterone treatment in men with multiple sclerosis

NeuroImage: Clinical

Volumn 4, Issue , 2014, Pages 454-460

  Kurth, Florian ^a   Luders, Eileen ^a   Sicotte, Nancy L ^a,b   Gaser, Christian ^c   Giesser, Barbara S ^a   Swerdloff, Ronald S ^d   Montag, Michael J ^a   Voskuhl, Rhonda R ^a   Mackenzie Graham, Allan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TESTOSTERONE; NEUROPROTECTIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DEGENERATIVE DISEASE; DISEASE MARKER; DRUG SAFETY; DRUG TOLERABILITY; FOCAL GRAY MATTER LOSS; FRONTAL CORTEX; GRAY MATTER; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM PARAMETERS; NEUROPROTECTION; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; VOXEL BASED MORPHOMETRY; YOUNG ADULT; BRAIN; CLINICAL TRIAL; DRUG EFFECTS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME;

ADULT; BRAIN; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPROTECTIVE AGENTS; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84896106673     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2014.03.001     Document Type: Article

References (50)

1. Ashburner J. A fast diffeomorphic image registration algorithm Neuroimage 38 2007 95 113 10.1016/j.neuroimage.2007.07.007 17761438 (Pubitemid 47440133)
2. Bach M.E., Hawkins R.D., Osman M., Kandel E.R., Mayford M. Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency Cell 81 1995 905 915 10.1016/0092-8674(95)90010-1 7781067
3. Bebo B.F. Jr., Schuster J.C., Vandenbark A.A., Offner H. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells Journal of Immunology 162 1999 35 40 9886367 (Pubitemid 29018901)
4. Bendfeldt K., Kuster P., Traud S., Egger H., Winklhofer S., Mueller-Lenke N., Naegelin Y., Gass A., Kappos L., Matthews P.M., Nichols T.E., Radue E.W., Borgwardt S.J. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - a longitudinal voxel-based morphometry study Neuroimage 45 2009 60 67 10.1016/j.neuroimage.2008.10.006 19013533
5. Bezzola L., Mérillat S., Gaser C., Jäncke L. Training-induced neural plasticity in golf novices Journal of Neuroscience: the Official Journal of the Society for Neuroscience 31 2011 12444 12448 10.1523/JNEUROSCI.1996-11. 2011 21880905
6. Bø L. The histopathology of grey matter demyelination in multiple sclerosis Acta Neurologica Scandinavica. Supplementum 2009 51 57 19566500
7. Boyke J., Driemeyer J., Gaser C., Buchel C., May A. Training-induced brain structure changes in the elderly Journal of Neuroscience: the Official Journal of the Society for Neuroscience 28 2008 7031 7035 10.1523/JNEUROSCI. 0742-08.2008 18614670
8. Brex P.A., Ciccarelli O., O'Riordan J.I., Sailer M., Thompson A.J., Miller D.H. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis New England Journal of Medicine 346 2002 158 164 10.1056/NEJMoa011341 11796849 (Pubitemid 34438881)
9. Byers J.S., Huguenard A.L., Kuruppu D., Liu N.K., Xu X.M., Sengelaub D.R. Neuroprotective effects of testosterone on motoneuron and muscle morphology following spinal cord injury Journal of Comparative Neurology 520 2012 2683 2696 10.1002/cne.23066
10. Cabeza R., Nyberg L. Imaging cognition II: an empirical review of 275 PET and fMRI studies Journal of Cognitive Neuroscience 12 2000 1 47 10.1162/08989290051137585 (Pubitemid 30142782)
11. Carroll J.C., Rosario E.R. The potential use of hormone-based therapeutics for the treatment of Alzheimer's disease Current Alzheimer Research 9 2012 18 34 10.2174/156720512799015109 22329650
12. Ceccarelli A., Jackson J.S., Tauhid S., Arora A., Gorky J., Dell'Oglio E., Bakshi A., Chitnis T., Khoury S.J., Weiner H.L., Guttmann C.R., Bakshi R., Neema M. The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis AJNR. American Journal of Neuroradiology 33 2012 1579 1585 10.3174/ajnr.A3083 22460341
13. Chard D.T., Griffin C.M., Rashid W., Davies G.R., Altmann D.R., Kapoor R., Barker G.J., Thompson A.J., Miller D.H. Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis Multiple Sclerosis (Houndmills, Basingstoke, England) 10 2004 387 391 10.1191/1352458504ms1050oa 15327034 (Pubitemid 39117333)
14. Chard D.T., Jackson J.S., Miller D.H., Wheeler-Kingshott C.A. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes Journal of Magnetic Resonance Imaging: JMRI 32 2010 223 228 10.1002/jmri.22214 20575080
15. Chen J.T., Narayanan S., Collins D.L., Smith S.M., Matthews P.M., Arnold D.L. Relating neocortical pathology to disability progression in multiple sclerosis using MRI Neuroimage 23 2004 1168 1175 10.1016/j.neuroimage.2004.07. 046 15528116 (Pubitemid 39446548)
16. Cuadra M.B., Cammoun L., Butz T., Cuisenaire O., Thiran J.P. Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images IEEE Transactions on Medical imaging 24 2005 1548 1565 10.1109/TMI.2005.857652 16350916 (Pubitemid 41812023)
17. Dalal M., Kim S., Voskuhl R.R. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response Journal of Immunology 159 1997 3 6 (Pubitemid 127493678)
18. Dalton C.M., Chard D.T., Davies G.R., Miszkiel K.A., Altmann D.R., Fernando K., Plant G.T., Thompson A.J., Miller D.H. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes Brain: a Journal of Neurology 127 2004 1101 1107 10.1093/brain/awh126 14998914 (Pubitemid 38623045)
19. Draganski B., Gaser C., Busch V., Schuierer G., Bogdahn U., May A. Neuroplasticity: changes in grey matter induced by training Nature 427 2004 311 312 10.1038/427311a 14737157 (Pubitemid 38133650)
20. Draganski B., Gaser C., Kempermann G., Kuhn H.G., Winkler J., Büchel C., May A. Temporal and spatial dynamics of brain structure changes during extensive learning Journal of Neuroscience: the Official Journal of the Society for Neuroscience 26 2006 6314 6317 10.1523/JNEUROSCI.4628-05.2006 16763039
21. Fisher E., Lee J.C., Nakamura K., Rudick R.A. Gray matter atrophy in multiple sclerosis: a longitudinal study Annals of Neurology 64 2008 255 265 10.1002/ana.21436 18661561
22. Gold S.M., Voskuhl R.R. Estrogen and testosterone therapies in multiple sclerosis Progress in Brain Research 175 2009 239 251 10.1016/S0079-6123(09) 17516-7 19660660
23. Grassiot B., Desgranges B., Eustache F., Defer G. Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review Journal of Neurology 256 2009 1397 1412 10.1007/s00415-009-5108-4 19353226
24. Hardmeier M., Wagenpfeil S., Freitag P., Fisher E., Rudick R.A., Kooijmans M., Clanet M., Radue E.W., Kappos L. Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a Neurology 64 2005 236 240 10.1212/01.WNL.0000149516.30155.B8 15668419
25. Healy B., Valsasina P., Filippi M., Bakshi R. Sample size requirements for treatment effects using gray matter, white matter and whole brain volume in relapsing-remitting multiple sclerosis Journal of Neurology, Neurosurgery, and Psychiatry 80 2009 1218 1223 10.1136/jnnp.2008.154732 19204021
26. Hussain R., Ghoumari A.M., Bielecki B., Steibel J., Boehm N., Liere P., Macklin W.B., Kumar N., Habert R., Mhaouty-Kodja S., Tronche F., Sitruk-Ware R., Schumacher M., Ghandour M.S. The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination Brain: a Journal of Neurology 136 2013 132 146 10.1093/brain/aws284 23365095
27. Luders E., Gaser C., Narr K.L., Toga A.W. Why sex matters: brain size independent differences in gray matter distributions between men and women Journal of Neuroscience: the Official Journal of the Society for Neuroscience 29 2009 14265 14270 10.1523/JNEUROSCI.2261-09.2009 19906974
28. Luders E., Kurth F., Toga A.W., Narr K.L., Gaser C. Meditation effects within the hippocampal complex revealed by voxel-based morphometry and cytoarchitectonic probabilistic mapping Frontiers in Psychology 4 2013 398 23847572
29. Manjón J.V., Coupé P., Martí-Bonmatí L., Collins D.L., Robles M. Adaptive non-local means denoising of MR images with spatially varying noise levels Journal of Magnetic Resonance Imaging: JMRI 31 2010 192 203 10.1002/jmri.22003 20027588
30. Miller D.H., Soon D., Fernando K.T., MacManus D.G., Barker G.J., Yousry T.A., Fisher E., O'Connor P.W., Phillips J.T., Polman C.H., Kappos L., Hutchinson M., Havrdova E., Lublin F.D., Giovannoni G., Wajgt A., Rudick R., Lynn F., Panzara M.A., Sandrock A.W. MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS Neurology 68 2007 1390 1401 10.1212/01.wnl. 0000260064.77700.fd 17452584 (Pubitemid 46659091)
31. Ontaneda D., Hyland M., Cohen J.A. Multiple sclerosis: new insights in pathogenesis and novel therapeutics Annual Review of Medicine 63 2012 389 404 10.1146/annurev-med-042910-135833 21888515
32. Pompl P.N., Mullan M.J., Bjugstad K., Arendash G.W. Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease Journal of Neuroscience Methods 87 1999 87 95 10.1016/S0165-0270(98)00169-1 10065997 (Pubitemid 29087089)
33. Prinster A., Quarantelli M., Orefice G., Lanzillo R., Brunetti A., Mollica C., Salvatore E., Morra V.B., Coppola G., Vacca G., Alfano B., Salvatore M. Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study Neuroimage 29 2006 859 867 10.1016/j.neuroimage.2005.08.034 16203159 (Pubitemid 43121211)
34. Rajapakse J.C., Giedd J.N., Rapoport J.L. Statistical approach to segmentation of single-channel cerebral MR images IEEE Transactions on Medical imaging 16 1997 176 186 10.1109/42.563663 9101327 (Pubitemid 127762929)
35. Ransome M.I. Androgen function in the pathophysiology and treatment of male Huntington's disease patients Journal of Neuroendocrinology 24 2012 1275 1283 10.1111/j.1365-2826.2012.02347.x 22672384
36. Rao A.B., Richert N., Howard T., Lewis B.K., Bash C.N., McFarland H.F., Frank J.A. Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b Neurology 59 2002 688 694 10.1212/WNL.59.5.688 12221158
37. Rudick R.A., Trapp B.D. Gray-matter injury in multiple sclerosis New England Journal of Medicine 361 2009 1505 1506 10.1056/NEJMcibr0905482 19812410
38. Schmidt P., Gaser C., Arsic M., Buck D., Förschler A., Berthele A., Hoshi M., Ilg R., Schmid V.J., Zimmer C., Hemmer B., Mühlau M. An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis Neuroimage 59 2012 3774 3783 10.1016/j.neuroimage.2011.11.032 22119648
39. Seeger T., Fedorova I., Zheng F., Miyakawa T., Koustova E., Gomeza J., Basile A.S., Alzheimer C., Wess J. M2 muscarinic acetylcholine receptor knockout mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity Journal of Neuroscience: the Official Journal of the Society for Neuroscience 24 2004 10117 10127 10.1523/JNEUROSCI.3581-04.2004 15537882 (Pubitemid 39492037)
40. Shattuck D.W., Leahy R.M. BrainSuite: an automated cortical surface identification tool Medical image Analysis 6 2002 129 142 10.1016/S1361-8415(02) 00054-3 12045000 (Pubitemid 35282822)
41. Sicotte N.L., Giesser B.S., Tandon V., Klutch R., Steiner B., Drain A.E., Shattuck D.W., Hull L., Wang H.J., Elashoff R.M., Swerdloff R.S., Voskuhl R.R. Testosterone treatment in multiple sclerosis: a pilot study Archives of Neurology 64 2007 683 688 10.1001/archneur.64.5.683 17502467 (Pubitemid 46789834)
42. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL Neuroimage 23 Suppl. 1 2004 S208 S219 10.1016/j.neuroimage.2004.07.051 15501092 (Pubitemid 39421720)
43. Smith S.M., Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference Neuroimage 44 2009 83 98 10.1016/j.neuroimage.2008.03.061 18501637
44. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., De Stefano N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis Neuroimage 17 2002 479 489 10.1006/nimg.2002.1040 12482100
45. Swerdloff R.S., Wang C. Androgens and the ageing male Best Practice & Research. Clinical Endocrinology & Metabolism 18 2004 349 362 10.1016/j.beem.2004.03.011 15261842 (Pubitemid 38992416)
46. Tiberio M., Chard D.T., Altmann D.R., Davies G., Griffin C.M., Rashid W., Sastre-Garriga J., Thompson A.J., Miller D.H. Gray and white matter volume changes in early RRMS: a 2-year longitudinal study Neurology 64 2005 1001 1007 10.1212/01.WNL.0000154526.22878.30 15781816 (Pubitemid 40388451)
47. Tohka J., Zijdenbos A., Evans A. Fast and robust parameter estimation for statistical partial volume models in brain MRI Neuroimage 23 2004 84 97 10.1016/j.neuroimage.2004.05.007 15325355 (Pubitemid 39119438)
48. Vigeveno R.M., Wiebenga O.T., Wattjes M.P., Geurts J.J., Barkhof F. Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration Journal of Magnetic Resonance Imaging: JMRI 36 2012 1 19 10.1002/jmri.23578 22696123
49. Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm IEEE Transactions on Medical imaging 20 2001 45 57 10.1109/42.906424 11293691 (Pubitemid 32293419)
50. Ziehn M.O., Avedisian A.A., Dervin S.M., Umeda E.A., O'Dell T.J., Voskuhl R.R. Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32 2012 12312 12324 10.1523/JNEUROSCI.2796-12.2012 22956822